Maternal neurofascin-specific autoantibodies bind to structures of the fetal nervous system during pregnancy, but have no long term effect on development in the rat.
<h4>Unlabelled</h4>Neurofascin was recently reported as a target for axopathic autoantibodies in patients with multiple sclerosis (MS), a response that will exacerbate axonal pathology and disease severity in an animal model of multiple sclerosis. As transplacental transfer of maternal a...
Main Authors: | Sonja Hochmeister, Thomas Pekar, Maren Lindner, Maja Kitic, Michaela Haindl, Maria Storch, Franz Fazekas, Christopher Linington |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24465550/pdf/?tool=EBI |
Similar Items
-
Discovery and Initial Characterizations of Neurofascin 155 High and Neurofascin 155 Low
by: Pomicter, Anthony
Published: (2008) -
Anti-neurofascin antibodies
by: Ng, King Man
Published: (2012) -
Systematic Review: Syndromes, Early Diagnosis, and Treatment in Autoimmune Encephalitis
by: Christina Hermetter, et al.
Published: (2018-09-01) -
Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke.
by: Sonja Hochmeister, et al.
Published: (2016-01-01) -
Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report
by: Paraskevi Kazakou, et al.
Published: (2018-10-01)